Remodeling of atrial ATP-sensitive K+ channels in a model of salt-induced elevated blood pressure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Lader, Joshua M ^a   Vasquez, Carolina ^a   Bao, Li ^a   Maass, Karen ^a   Qu, Jiaxiang ^a   Kefalogianni, Eirini ^a   Fishman, Glenn I ^a   Coetzee, William A ^a   Morley, Gregory E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Action potentials; Arrhythmia mechanisms; Cardiac remodeling; Potassium channel; Salt sensitivity hypertension

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CHLORIDE; SULFONYLUREA RECEPTOR 1; TOLBUTAMIDE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART LEFT ATRIUM; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HEART MUSCLE REFRACTORY PERIOD; HEART REPOLARIZATION; HIGH SALT DIET; HYPERTENSION; IN VIVO STUDY; ISOLATED HEART; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RISK ASSESSMENT; SALT INDUCED ELEVATED BLOOD PRESSURE; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; ATRIAL FIBRILLATION; ATRIAL FUNCTION; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; FIBROSIS; HEART ATRIA; HYPERTENSION; KATP CHANNELS; MALE; MICE; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SARCOLEMMA; SODIUM CHLORIDE, DIETARY; TIME FACTORS; VOLTAGE-SENSITIVE DYE IMAGING;

EID: 80052313607     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00410.2011     Document Type: Article

References (95)

1. Allessie MA, Konings K, Kirchhof CJ, Wijffels M. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 77: 10A-23A, 1996.
2. Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC. Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily. Genomics 47: 187-199, 1998.
3. ATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ Res 83: 1132-1143, 1998.
4. Balana B, Dobrev D, Wettwer E, Christ T, Knaut M, Ravens U. Decreased ATP-sensitive K current density during chronic human atrial fibrillation. J Mol Cell Cardiol 35: 1399-1405, 2003.
5. ATP channels as a reservoir after myocardial ischemia: a role for SUR2 subunits. Am J Physiol Heart Circ Physiol 300: H262-H270, 2011.
6. ATP channels. Science 282: 1141-1144, 1998.
7. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271: 840-844, 1994.
8. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98: 946-952, 1998.
9. Billman GE. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy. Pharmacol Ther 120: 54-70, 2008.
10. Bode F, Katchman A, Woosley RL, Franz MR. Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation 101: 2200-2205, 2000.
11. Bode F, Sachs F, Franz MR. Tarantula peptide inhibits atrial fibrillation. Nature 409: 35-36, 2001.
12. Briefel RR, Johnson CL. Secular trends in dietary intake in the United States. Annu Rev Nutr 24: 401-431, 2004.
13. Brundel BJ, Van Gelder IC, Henning RH, Tuinenburg AE, Wietses M, Grandjean JG, Wilde AA, Van Gilst WH, Crijns HJ. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K channels. J Am Coll Cardiol 37: 926-932, 2001.
14. Calkins H, el-Atassi R, Kalbfleisch S, Langberg J, Morady F. Effects of an acute increase in atrial pressure on atrial refractoriness in humans. Pacing Clin Electrophysiol 15: 1674-1680, 1992.
15. Carrasco AJ, Dzeja PP, Alekseev AE, Pucar D, Zingman LV, Abraham MR, Hodgson D, Bienengraeber M, Puceat M, Janssen E, Wieringa B, Terzic A. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc Natl Acad Sci USA 98: 7623-7628, 2001.
16. Cha TJ, Ehrlich JR, Chartier D, Qi XY, Xiao L, Nattel S. Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias. Circulation 113: 1730-1737, 2006.
17. Chen YJ, Chen SA, Tai CT, Wen ZC, Feng AN, Ding YA, Chang MS. Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation. J Am Coll Cardiol 32: 732-738, 1998.
18. Chen YJ, Tai CT, Chiou CW, Wen ZC, Chan P, Lee SH, Chen SA. Inducibility of atrial fibrillation during atrioventricular pacing with varying intervals: role of atrial electrophysiology and the autonomic nervous system. J Cardiovasc Electrophysiol 10: 1578-1585, 1999.
19. Choisy SC, Arberry LA, Hancox JC, James AF. Increased susceptibility to atrial tachyarrhythmia in spontaneously hypertensive rat hearts. Hypertension 49: 498-505, 2007.
20. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS. Differential cardiac effects of growth hormone and insulinlike growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 93: 800-809, 1996.
21. ATP channel subunit essential for cell protection against ischemia. EMBO J 21: 3936-3948, 2002.
22. Crawford RM, Ranki HJ, Botting CH, Budas GR, Jovanovic A. Creatine kinase is physically associated with the cardiac ATP-sensitive K channel in vivo. FASEB J 16: 102-104, 2002.
23. Danik SB, Rosner G, Lader J, Gutstein DE, Fishman GI, Morley GE. Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts. FASEB J 22: 1204-1212, 2007.
24. Diness JG, Skibsbye L, Jespersen T, Bartels ED, Sorensen US, Hansen RS, Grunnet M. Effects on atrial fibrillation in aged hypertensive rats by Ca2-activated K channel inhibition. Hypertension 57: 1129-1135.
25. Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, Knaut M, Ravens U. The G protein-gated potassium current IK,ACh is constitutively active in patients with chronic atrial fibrillation. Circulation 112: 3697-3706, 2005.
26. Dobrev D, Graf E, Wettwer E, Himmel HM, Hala O, Doerfel C, Christ T, Schuler S, Ravens U. Molecular basis of downregulation of G-proteincoupled inward rectifying K current (IK,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced IK,ACh and muscarinic receptor-mediated shortening of action potentials. Circulation 104: 2551-2557, 2001.
27. Du Q, Jovanovic S, Clelland A, Sukhodub A, Budas G, Phelan K, Murray-Tait V, Malone L, Jovanovic A. Overexpression of SUR2A generates a cardiac phenotype resistant to ischemia. FASEB J 20: 1131-1141, 2006.
28. Fedorov VV, Lozinsky IT, Sosunov EA, Anyukhovsky EP, Rosen MR, Balke CW, Efimov IR. Application of blebbistatin as an excitationcontraction uncoupler for electrophysiologic study of rat and rabbit hearts. Heart Rhythm 4: 619-626, 2007.
29. ATP channels require SUR1. Circ Res 103: 1458-1465, 2008.
30. Franz MR, Burkhoff D, Yue DT, Sagawa K. Mechanically induced action potential changes and arrhythmia in isolated and in situ canine hearts. Cardiovasc Res 23: 213-223, 1989.
31. Gaborit N, Le Bouter S, Szuts V, Varro A, Escande D, Nattel S, Demolombe S. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. J Physiol 582: 675-693, 2007.
32. ATP channel pharmacology in intact mouse heart. J Mol Cell Cardiol 48: 152-160, 2010.
33. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285: 2370-2375, 2001.
34. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 94: 2968-2974, 1996.
35. Gribble FM, Tucker SJ, Ashcroft FM. The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K channel currents expressed in Xenopus oocytes: a reinterpretation. J Physiol 504: 35-45, 1997.
36. ATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 285: H921-H930, 2003.
37. Hagiwara N, Masuda H, Shoda M, Irisawa H. Stretch-activated anion currents of rabbit cardiac myocytes. J Physiol 456: 285-302, 1992.
38. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100, 1981.
39. Hansen DE, Craig CS, Hondeghem LM. Stretch-induced arrhythmias in the isolated canine ventricle. Evidence for the importance of mechanoelectrical feedback. Circulation 81: 1094-1105, 1990.
40. Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol 79: 508-511, 1997.
41. Isidoro Tavares N, Philip-Couderc P, Baertschi AJ, Lerch R, Montessuit C. Angiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failure. Cardiovasc Res 83: 726-736, 2009.
42. James AF, Kim SJ, Zhang H, Choisy SC, Lin H, Hancox JC, Suleiman MS. Anti-arrhythmic action of an ATP-sensitive potassium channel blocker against atrial fibrillation associated with-adrenergic stress in rat hearts. Biophys J; doi:10.1016/j.bpj.2010.12.1290.
43. Jayachandran JV, Zipes DP, Weksler J, Olgin JE. Role of the Na/H exchanger in short-term atrial electrophysiological remodeling. Circulation 101: 1861-1866, 2000.
44. ATP channel. EMBO Rep 6: 848-852, 2005.
45. Jovanovic S, Jovanovic A. High glucose regulates the activity of cardiac sarcolemmal ATP-sensitive K channels via 1,3-bisphosphoglycerate: a novel link between cardiac membrane excitability and glucose metabolism. Diabetes 54: 383-393, 2005.
46. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: populationbased estimates. Am J Cardiol 82: 2N-9N, 1998.
47. Kantor PF, Coetzee WA, Carmeliet EE, Dennis SC, Opie LH. Reduction of ischemic K loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res 66: 478-485, 1990.
48. Kaseda S, Zipes DP. Contraction-excitation feedback in the atria: a cause of changes in refractoriness. J Am Coll Cardiol 11: 1327-1336, 1988.
49. Kistler PM, Sanders P, Dodic M, Spence SJ, Samuel CS, Zhao C, Charles JA, Edwards GA, Kalman JM. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J 27: 3045-3056, 2006.
50. Klein LS, Miles WM, Zipes DP. Effect of atrioventricular interval during pacing or reciprocating tachycardia on atrial size, pressure, and refractory period. Contraction-excitation feedback in human atrium. Circulation 82: 60-68, 1990.
51. Koumi SI, Martin RL, Sato R. Alterations in ATP-sensitive potassium channel sensitivity to ATP in failing human hearts. Am J Physiol Heart Circ Physiol 272: H1656-H1665, 1997.
52. Kulan K, Ural D, Komsuoglu B, Agacdiken A, Goldeli O, Komsuoglu SS. Significance of QTc prolongation on ventricular arrhythmias in patients with left ventricular hypertrophy secondary to essential hypertension. Int J Cardiol 64: 179-184, 1998.
53. Lau DH, Mackenzie L, Kelly DJ, Psaltis PJ, Worthington M, Rajendram A, Kelly DR, Nelson AJ, Zhang Y, Kuklik P, Brooks AG, Worthley SG, Faull RJ, Rao M, Edwards J, Saint DA, Sanders P. Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model. Heart Rhythm 7: 396-404, 2010.
54. Le Grand B, Hatem S, Le Heuzey JY, Deroubaix E, Benitah JP, Coraboeuf E. Pro-arrhythmic effect of nicorandil in isolated rabbit atria and its suppression by tolbutamide and quinidine. Eur J Pharmacol 229: 91-96, 1992.
55. Leaf D, Feig JE, Vasquez C, Riva PL, Yu C, Lader JM, Kontogeorgis A, Peters NS, Fisher EA, Gutstein DE, Morley GE. Connexin40 imparts conduction heterogeneity to atrial tissue. Circ Res 103: 1001-1008, 2008.
56. Lorenz E, Terzic A. Physical association between recombinant cardiac ATP-sensitive K channel subunits Kir6.2 and SUR2A. J Mol Cell Cardiol 31: 425-434, 1999.
57. Mayet J, Shahi M, McGrath K, Poulter NR, Sever PS, Foale RA, Thom SA. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 28: 791-796, 1996.
58. McIntosh MA, Cobbe SM, Kane KA, Rankin AC. Action potential prolongation and potassium currents in left-ventricular myocytes isolated from hypertrophied rabbit hearts. J Mol Cell Cardiol 30: 43-53, 1998.
59. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85: 679-715, 2005.
60. Morley GE, Vaidya D, Samie FH, Lo CW, Delmar M, Jalife J. Characterization of conduction in the ventricles of normal and heterozygous connexin43 knockout mice using optical mapping. J Cardiovasc Electrophysiol 10: 1361-1375, 1999.
61. Nattel S, Burstein B, Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythm Electrophysiol 1: 62-73, 2008.
62. Nattel S, Shiroshita-Takeshita A, Brundel BJ, Rivard L. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis 48: 9-28, 2005.
63. ATP channels as molecular sensors of cellular metabolism. Nature 440: 470-476, 2006.
64. Noma A. ATP-regulated K channels in cardiac muscle. Nature 305: 147-148, 1983.
65. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 87: 460-466, 2000.
66. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, Salvati A, Dicandia C, Calabro MP, Mazzone P, Ficarra E, Di Gioia C, Gulletta S, Nardi S, Santinelli V, Benussi S, Alfieri O. Atrial electroanatomic remodeling after circumferential radiofrequency pulmo-nary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 104: 2539-2544, 2001.
67. 2+ release in cardiomyocytes. Nat Cell Biol 3: 867-873, 2001.
68. ATP channel subunits and energy metabolism. Circ Res 102: e20-e35, 2008.
69. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 96: 1686-1695, 1997.
70. Saad MJ, Velloso LA, Carvalho CR. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem J 310: 741-744, 1995.
71. ATP channel acts as a negative feedback mechanism? Cardiovasc Res 67: 60-68, 2005.
72. Sato R, Koumi S. Characterization of the stretch-activated chloride channel in isolated human atrial myocytes. J Membr Biol 163: 67-76, 1998.
73. Shigematsu S, Sato T, Abe T, Saikawa T, Sakata T, Arita M. Pharmacological evidence for the persistent activation of ATP-sensitive K channels in early phase of reperfusion and its protective role against myocardial stunning. Circulation 92: 2266-2275, 1995.
74. Shinagawa K, Shi YF, Tardif JC, Leung TK, Nattel S. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 105: 2672-2678, 2002.
75. Shinohara T, Takahashi N, Kohno H, Yamanaka K, Ooie T, Wakisaka O, Murozono Y, Taniguchi Y, Torigoe Y, Hara M, Shimada T, Saikawa T, Yoshimatsu H. Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart. Am J Physiol Heart Circ Physiol 293: H1892-H1899, 2007.
76. Shiroshita-Takeshita A, Mitamura H, Ogawa S, Nattel S. Rate-dependence of atrial tachycardia effects on atrial refractoriness and atrial fibrillation maintenance. Cardiovasc Res 81: 90-97, 2009.
77. Stiles MK, John B, Wong CX, Kuklik P, Brooks AG, Lau DH, Dimitri H, Roberts-Thomson KC, Wilson L, De Sciscio P, Young GD, Sanders P. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor". J Am Coll Cardiol 53: 1182-1191, 2009.
78. Suarez E, Bach D, Cadefau J, Palacin M, Zorzano A, Guma A. A novel role of neuregulin in skeletal muscle. Neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells. J Biol Chem 276: 18257-18264, 2001.
79. Suzuki M, Li RA, Miki T, Uemura H, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Ogura T, Seino S, Marban E, Nakaya H. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res 88: 570-577, 2001.
80. Terzic A, Tung RT, Inanobe A, Katada T, Kurachi Y. G proteins activate ATP-sensitive K channels by antagonizing ATP-dependent gating. Neuron 12: 885-893, 1994.
81. Tosaki A, Engelman DT, Engelman RM, Das DK. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/ reperfused hearts. J Pharmacol Exp Ther 275: 1115-1123, 1995.
82. Tosaki A, Hellegouarch A. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts. J Am Coll Cardiol 23: 487-496, 1994.
83. Tseng GN. Cell swelling increases membrane conductance of canine cardiac cells: evidence for a volume-sensitive Cl channel. Am J Physiol Cell Physiol 262: C1056-C1068, 1992.
84. Tsuchiya K, Horie M, Watanuki M, Albrecht CA, Obayashi K, Fujiwara H, Sasayama S. Functional compartmentalization of ATP is involved in angiotensin II-mediated closure of cardiac ATP-sensitive K channels. Circulation 96: 3129-3135, 1997.
85. ATP channel inhibition by ATP. EMBO J 17: 3290-3296, 1998.
86. Vaidya D, Morley GE, Samie FH, Jalife J. Reentry and fibrillation in the mouse heart: a challenge to the critical mass hypothesis. Circ Res 85: 174-181, 1999.
87. ATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol 280: H246-H255, 2001.
88. ATP channels by diazoxide. Circulation 104: 85-90, 2001.
89. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 96: 3710-3720, 1997.
90. Wolleben CD, Sanguinetti MC, Siegl PK. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J Mol Cell Cardiol 21: 783-788, 1989.
91. Wu G, Huang CX, Tang YH, Jiang H, Wan J, Chen H, Xie Q, Huang ZR. Changes of IK,ATP current density and allosteric modulation during chronic atrial fibrillation. Chin Med J (Engl) 118: 1161-1166, 2005.
92. Yu Q, Larson DF, Slayback D, Lundeen TF, Baxter JH, Watson RR. Characterization of high-salt and high-fat diets on cardiac and vascular function in mice. Cardiovasc Toxicol 4: 37-46, 2004.
93. Yue L, Feng J, Gaspo R, Li GR, Wang Z, Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 81: 512-525, 1997.
94. Zarse M, Stellbrink C, Athanatou E, Robert J, Schotten U, Hanrath P. Verapamil prevents stretch-induced shortening of atrial effective refractory period in langendorff-perfused rabbit heart. J Cardiovasc Electrophysiol 12: 85-92, 2001.
95. Zheng S, Noonan WT, Metreveli NS, Coventry S, Kralik PM, Carlson EC, Epstein PN. Development of late-stage diabetic nephropathy in OVE26 diabetic mice. Diabetes 53: 3248-3257, 2004.